Solid tumors of childhood display specific serum microRNA profiles

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 2, 2015, Pages 350-360

  Murray, Matthew J ^a,b   Raby, Katie L ^b   Saini, Harpreet K ^c   Bailey, Shivani ^a,b   Wool, Sophie V ^a   Tunnacliffe, Jane M ^a   Enright, Anton J ^c   Nicholson, James C ^a   Coleman, Nicholas ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 124-3P; MICRORNA 1538; MICRORNA 218-5P; MICRORNA 490-5P; MICRORNA 9-3P; UNCLASSIFIED DRUG; RNA; TUMOR MARKER;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FEMALE; GENE EXPRESSION; GLIOMA; HEMOLYSIS; HEPATOBLASTOMA; HIGH RISK PATIENT; HUMAN; INFANT; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PLEUROPULMONARY BLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA EXTRACTION; SARCOMA; SCHOOL CHILD; SOLID TUMOR; BLOOD; CLINICAL TRIAL; NEOPLASM; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; BIOMARKERS, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICRORNAS; NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 84922718826     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0669     Document Type: Article

References (31)

1. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, et al. Malignant germ cell tumors display common micro-RNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 2010;70:2911-23.
2. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435: 834-8.
3. Murray MJ, Halsall DJ, Hook CE, Williams DM, Nicholson JC, Coleman N. Identification of Micro RNAs fromthemiR-371373 andmiR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 2011;135:119-25.
4. Gillis AJ, Rijlaarsdam MA, Eini R, Dorssers LC, Biermann K, Murray MJ, et al. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol Oncol 2013;7:1083-92.
5. Murray MJ, Coleman N. Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol 2012;9:298-300.
6. Belge G, Dieckmann KP, Spiekermann M, Balks T, Bullerdiek J. Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers fortesticular germ cell tumors? Eur Urol 2012;61:1068-9.
7. Dieckmann KP, Spiekermann M, Balks T, Flor I, Loning T, Bullerdiek J, et al. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 2012;107:1754-60.
8. Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, et al. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Andrology 2014; Epub ahead of print.
9. Syring I, Bartels J, Holdenrieder S, Kristiansen G, Muller SC, Ellinger J. Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers. J Urol 2014:pii:S0022-5347(14)03957-3, Epub ahead of print.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agad-janyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-8.
11. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009;100:1471-82.
12. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-22.
13. Murray MJ, Bailey S, Raby KL, Saini HK, de Kock L, Burke GA, et al. Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blas-toma. Oncogenesis 2014;3:e87.
14. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
15. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
16. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245-50.
17. Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 2012;28:573-80.
18. Vosa U, Vooder T, Kolde R, Vilo J, Metspalu A, Annilo T. Meta-analysis of microRNA expression in lung cancer. Int J Cancer 2013;132:2884-93.
19. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 2013;59:S1-6.
20. Anglesio MS, Wang Y, Yang W, Senz J, Wan A, Heravi-Moussavi A, et al.Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol 2013;229:400-9.
21. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, et al.LNA-mediated microRNA silencing in non-human primates. Nature 2008;452:896-9.
22. Kessler OJ, Siegel JF, Brock WA. Intrarenal neuroblastomamasquerading as Wilms' tumor. Urology 1998;51:313-6.
23. Sellaturay SV, Arya M, Banisadr S, Murthi GV, Sebire NJ, Duffy PG. Primary intrarenal neuroblastoma: a rare, aggressive tumour of childhood mimicking Wilms' tumour. J Pediatr Urol 2006;2:522-4.
24. Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, et al. Neuroblastoma mRNAs predict outcome inchildren with stage4 neuroblas-toma: a European HR-NBL1/SIOPEN study. J Clin Oncol 2014;32:1074-83.
25. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002;48:1883-90.
26. Viprey VF, Corrias MV, Kagedal B, Oltra S, Swerts K, Vicha A, et al. Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 2007;43:341-50.
27. Chen Y, Stallings RL. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apopto-sis. Cancer Res 2007;67:976-83.
28. Huang TC, Chang HY, Chen CY, Wu PY, Lee H, Liao YF, et al. Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Lett 2011;585:3582-6.
29. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010;12:247-56.
30. Gyugos M, Lendvai G, Kenessey I, Schlachter K, Halasz J, Nagy P, et al. MicroRNA expression might predict prognosis of epithelial hepatoblas-toma. Virchows Arch 2014;464:419-27.
31. Shifeng H, Danni W, Pu C, Ping Y, Ju C, Liping Z. Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury. PLoS ONE 2013;8:e73133.